The Reagan-Udall Foundation for the FDA, in collaboration with the Food and Drug Administration (FDA), is hosting a public webinar as part of a series of webinars for FDA-issued guidance related to real-world evidence (RWE). This latest session in the webinar series will discuss the draft guidance: Integrating Randomized Controlled Trials for Drug and Biological Products Into Routine Clinical Practice.

This free, public event will explore key immunology-related topics that have implications across the class of AAV gene therapies, including immune responses, antibody testing, and redosing strategies.

Stay tuned for more details

With well over 5,000 attendees the Festival is now the [...]

This year, NCATS and the U.S. Food and Drug Administration [...]

This inaugural virtual event March 12 and 13, 2025 (9 [...]

The Advanced Therapies Congress is Europe’s largest commerical cell and [...]

The Rare Disease Summit connects key stakeholders to drive therapeutic [...]

Join peers to drive gene therapy innovation across translational, clinical, regulatory, and manufacturing tracks.

Meet the global CRISPR Medicine community at the second CRISPR MEDiCiNE conference.

The 2025 programme will highlight non-coding variants and the implication [...]

Human Genetics and Genetical Disorders-2025 extend our immense pleasure and honor [...]

Stay tuned for more information on ASGCT's 2025 annual meeting. [...]

Engage with analytical leads to discuss shared pain points, new [...]

The Cell and Gene Therapy Products (CGTP) Symposium: Manufacturing, Quality [...]

The Festival is designed principally for scientists and clinicians who are [...]

We cordially invite you to The Global Cell & Gene [...]

The specific goal for this meeting is to foster fruitful [...]

The Cell & Gene Therapy World Conference 2025 (CGTWC 2025), [...]

Shape the future of rare disease treatments, research and policy [...]